CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-10 | Malik Fady Ibraham EVP Research & Development | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −5,300 | 0 | ||
| 2024-12-03 | Wong Robert VP, Chief Accounting Officer | Grant or award | +764 | 18,162 | ||
| 2024-12-03 | Wong Robert VP, Chief Accounting Officer | Shares withheld for taxes | −273 | $51.51 | $14K | 17,889 |
| 2024-12-03 | Wong Robert VP, Chief Accounting Officer | Grant or award | +766 | 18,655 | ||
| 2024-12-03 | Lee Sung EVP, Chief Financial Officer | Grant or award | +4,303 | 38,987 | ||
| 2024-12-03 | Lee Sung EVP, Chief Financial Officer | Shares withheld for taxes | −1,536 | $51.51 | $79K | 37,451 |
| 2024-12-03 | Lee Sung EVP, Chief Financial Officer | Grant or award | +4,304 | 41,755 | ||
| 2024-12-03 | Malik Fady Ibraham EVP Research & Development | Grant or award | +4,000 | 116,099 | ||
| 2024-12-03 | Malik Fady Ibraham EVP Research & Development | Shares withheld for taxes | −2,028 | $51.51 | $104K | 114,071 |
| 2024-12-03 | Malik Fady Ibraham EVP Research & Development | Grant or award | +4,000 | 118,071 | ||
| 2024-12-03 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +3,176 | 67,063 | ||
| 2024-12-03 | Callos Andrew EVP, Chief Commercial Officer | Shares withheld for taxes | −1,351 | $51.51 | $70K | 65,712 |
| 2024-12-03 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +3,177 | 68,889 | ||
| 2024-12-03 | Blum Robert I President & CEO | Grant or award | +11,529 | 409,207 | ||
| 2024-12-03 | Blum Robert I President & CEO | Shares withheld for taxes | −5,843 | $51.51 | $301K | 403,364 |
| 2024-12-03 | Blum Robert I President & CEO | Grant or award | +11,530 | 414,894 | ||
| 2024-12-02 | Blum Robert I President & CEO | Option exercise 10b5-1 | +5,000 | $6.67 | $33K | 402,678 |
| 2024-12-02 | Blum Robert I President & CEO | Sale 10b5-1 | −5,000 | $50.76 | $254K | 397,678 |
| 2024-12-02 | Blum Robert I President & CEO | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −5,000 | 54,727 | ||
| 2024-11-26 | Malik Fady Ibraham EVP Research & Development | Option exercise 10b5-1 | +5,300 | $7.96 | $42K | 119,178 |
Page 25 of 33 · 660 trades